JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 14, 2005; DOI: 10.1124/jpet.105.090589


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.090589v1
316/1/106    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neye, Y.
Right arrow Articles by Krippeit-Drews, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neye, Y.
Right arrow Articles by Krippeit-Drews, P.


Received for publication June 6, 2005.
Revised September 9, 2005.
Accepted for publication September 12, 2005.

HIV protease inhibitors: Suppression of insulin secretion by inhibition of voltage-dependent K+ currents and anion currents

Yvonne Neye 1, Martina Duefer 1, Gisela Drews 1, Peter Krippeit-Drews 1*

1 Pharmazeutisches Institut, Universitat Tuebingen

* Address correspondence to: E-mail: peter.krippeit-drews{at}uni-tuebingen.de

Abstract

We have shown before that the HIV protease inhibitors ritonavir and nelfinavir, but not indinavir suppress insulin secretion from mouse pancreatic B-cells via reduction of the cytosolic free calcium concentration ([Ca2+]c). This was not owing to an effect on ATP-dependent K+ channels (KATP channels) or L-type Ca2+ channels. The study was intended to elucidate the mechanisms by which distinct HIV protease inhibitors decrease [Ca2+]c and thus evoke their adverse side effect on insulin release. Membrane potential and whole-cell currents were measured with the patch-clamp technique and [Ca2+]c was determined with a fluorescence dye. Ritonavir and nelfinavir both inhibited the same component(s) of voltage-dependent K+ currents with a concomitant change in action potential waveform, while indinavir was ineffective. Comparison with other blockers of voltage-dependent K+ currents revealed that suppression of distinct non-inactivating current component(s) altered action potential waveform and decreased [Ca2+]c similar to ritonavir and nelfinavir whereas blockage of inactivating component(s) was without effect. Complete inhibition of voltage-dependent K+ currents by 80 mM TEA+ drastically increased [Ca2+]c demonstrating that voltage-dependent K+ channels are not the sole target of ritonavir and nelfinavir. Accordingly, the Ca2+-lowering effect of ritonavir was preserved in the presence of 80 mM TEA+. This effect was mimicked by the anion channel blocker DIDS. Consequentially, ritonavir and nelfinavir inhibited a DIDS-sensitive anion current in B-cells. We suggest that ritonavir and nelfinavir decrease insulin secretion by inhibition of voltage-dependent K+ channels and anion channels which are essential to provide counterion currents for Ca2+ influx across the plasma membrane.


Key words: cytosolic calcium concentration, insulin secretion, nelfinavir, ritonavir, voltage dependent potassium current, volume sensitive anion current





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.